[PHARMA] QoQ Cumulative Quarter Result on 31-Mar-2022 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
20-May-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
31-Mar-2022 [#1]
Profit Trend
QoQ- -83.89%
YoY- 19.87%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 3,510,677 2,647,957 1,723,276 962,174 4,815,015 4,103,297 1,970,622 46.80%
PBT -580,846 57,549 41,960 37,439 277,075 151,987 53,768 -
Tax -24,204 -18,402 -12,190 -8,583 -104,870 -64,947 -17,052 26.22%
NP -605,050 39,147 29,770 28,856 172,205 87,040 36,716 -
-
NP to SH -607,317 37,073 28,456 27,734 172,150 86,675 36,840 -
-
Tax Rate - 31.98% 29.05% 22.93% 37.85% 42.73% 31.71% -
Total Cost 4,115,727 2,608,810 1,693,506 933,318 4,642,810 4,016,257 1,933,906 65.22%
-
Net Worth -248,894 411,327 406,087 413,947 450,411 391,428 357,275 -
Dividend
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Div 24,889 24,889 17,029 10,479 121,768 56,292 30,100 -11.87%
Div Payout % 0.00% 67.14% 59.84% 37.79% 70.73% 64.95% 81.71% -
Equity
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Net Worth -248,894 411,327 406,087 413,947 450,411 391,428 357,275 -
NOSH 1,309,126 1,309,126 1,309,126 1,309,126 1,309,336 1,309,126 261,991 191.42%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -17.23% 1.48% 1.73% 3.00% 3.58% 2.12% 1.86% -
ROE 0.00% 9.01% 7.01% 6.70% 38.22% 22.14% 10.31% -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
RPS 268.00 202.14 131.55 73.45 367.74 313.44 150.58 46.70%
EPS -46.36 2.83 2.17 2.12 13.15 6.62 2.82 -
DPS 1.90 1.90 1.30 0.80 9.30 4.30 2.30 -11.92%
NAPS -0.19 0.314 0.31 0.316 0.344 0.299 0.273 -
Adjusted Per Share Value based on latest NOSH - 1,309,126
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
RPS 243.58 183.73 119.57 66.76 334.08 284.70 136.73 46.80%
EPS -42.14 2.57 1.97 1.92 11.94 6.01 2.56 -
DPS 1.73 1.73 1.18 0.73 8.45 3.91 2.09 -11.81%
NAPS -0.1727 0.2854 0.2818 0.2872 0.3125 0.2716 0.2479 -
Price Multiplier on Financial Quarter End Date
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Date 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 -
Price 0.545 0.515 0.595 0.755 0.74 0.835 5.29 -
P/RPS 0.20 0.25 0.45 1.03 0.20 0.27 3.51 -85.11%
P/EPS -1.18 18.20 27.39 35.66 5.63 12.61 187.92 -
EY -85.07 5.50 3.65 2.80 17.77 7.93 0.53 -
DY 3.49 3.69 2.18 1.06 12.57 5.15 0.43 302.32%
P/NAPS 0.00 1.64 1.92 2.39 2.15 2.79 19.38 -
Price Multiplier on Announcement Date
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Date 27/02/23 24/11/22 19/08/22 20/05/22 17/02/22 19/11/21 20/08/21 -
Price 0.44 0.55 0.595 0.72 0.76 0.845 0.925 -
P/RPS 0.16 0.27 0.45 0.98 0.21 0.27 0.61 -58.92%
P/EPS -0.95 19.43 27.39 34.01 5.78 12.76 32.86 -
EY -105.37 5.15 3.65 2.94 17.30 7.84 3.04 -
DY 4.32 3.45 2.18 1.11 12.24 5.09 2.49 44.24%
P/NAPS 0.00 1.75 1.92 2.28 2.21 2.83 3.39 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment